Aquestive Therapeutics (AQST) announced the promotion of Sherry Korczynski, from Senior Vice President of Sales and Marketing, to Chief Commercial Officer effective July 22, 2025.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AQST:
- Aquestive Therapeutics provides international expansion update for Anaphylm
- Aquestive Therapeutics announces two presentations on Anaphylm
- Positive Outlook for Aquestive Therapeutics Amidst FDA Progress and Strategic Preparations for Anaphylm Launch
- Buy Rating for Aquestive Therapeutics Driven by Anaphylm’s FDA Progress and Market Potential
- FDA Accepts Aquestive’s New Drug Application for Anaphylm